You are here

Medicare

AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program

AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program

BioSpace

Bristol Myers Squibb

Inflation Reduction Act

Flag link:

FDA greenlights Jardiance for treating chronic kidney disease

FDA greenlights Jardiance for treating chronic kidney disease

Medical Marketing and Media

Boehringer Ingelheim

chronic kidney disease

Flag link:

DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations

DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations

BioSpace

Inflation Reduction Act

Flag link:

How Payers Are Reacting to Insulin Price Changes

How Payers Are Reacting to Insulin Price Changes

Drug Channels

Inflation Reduction Act

Flag link:

Astellas withdraws lawsuit challenging Medicare drug price negotiation plans

Astellas withdraws lawsuit challenging Medicare drug price negotiation plans

Reuters

prostate cancer

Inflation Reduction Act

Flag link:

Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?

Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?

Motley Fool

Flag link:

Novartis hits back at Entresto selection on Medicare list

Novartis hits back at Entresto selection on Medicare list

Pharmaphorum

Flag link:

Biden administration lists 10 drugs for Medicare price negotiation

Biden administration lists 10 drugs for Medicare price negotiation

Medical Marketing and Media

Bristol Myers Squibb

Boehringer Ingelheim

Flag link:

Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions

Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions

BioSpace

Boehringer Ingelheim

Inflation Reduction Act

Flag link:

AARP urges courts to keep drug pricing talks on track

AARP urges courts to keep drug pricing talks on track

Yahoo Finance

Flag link:

The 10 drugs that CMS might wrangle into negotiations

The 10 drugs that CMS might wrangle into negotiations

Beckers Hospital Review

Bristol Myers Squibb

Boehringer Ingelheim

Flag link:

Median lag between FDA authorization and Medicare coverage hits 6 years: study

Median lag between FDA authorization and Medicare coverage hits 6 years: study

Medtech Dive

Flag link:

What's a fair price for a prescription drug? Medicare's about to weigh in

What's a fair price for a prescription drug? Medicare's about to weigh in

NPR

Flag link:

Medicare proposes coverage for PrEP without patient cost sharing

Medicare proposes coverage for PrEP without patient cost sharing

Fierce Healthcare

Flag link:

How will the price of Eisai and Biogen's Leqembi impact Medicare? Sen. Sanders wants to know

How will the price of Eisai and Biogen's Leqembi impact Medicare? Sen. Sanders wants to know

Fierce Pharma

Alzheimer's disease

Flag link:

Medtronic secures Medicare coverage for MiniMed 780G insulin pump

Medtronic secures Medicare coverage for MiniMed 780G insulin pump

Medtech Dive

Flag link:

Medicare has no surprises in planned registry for new Alzheimer’s drugs

Medicare has no surprises in planned registry for new Alzheimer’s drugs

BioPharma Dive

Alzheimer's disease

Flag link:

PhRMA sues Biden administration over Medicare drug price negotiations

PhRMA sues Biden administration over Medicare drug price negotiations

The Hill

Inflation Reduction Act

Flag link:

Biopharma Execs Weigh Controversial Move: Opting Out of Medicare to Escape Drug Price Negotiations

Biopharma Execs Weigh Controversial Move: Opting Out of Medicare to Escape Drug Price Negotiations

BioSpace

Inflation Reduction Act

biopharma exectuives

Flag link:

BMS Follows Merck’s Lead, Sues Government Over Drug Pricing Negotiation

BMS Follows Merck’s Lead, Sues Government Over Drug Pricing Negotiation

BioSpace

Bristol Myers Squibb

Inflation Reduction Act

Flag link:

Pages